Masoumeh Kourosh Arami

Dr. Masoumeh Kourosh Arami

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Reviews in the Neurosciences
Verified
Journal Article
Closed access
MAMasoumeh Kourosh Arami
Masoumeh Kourosh Arami
NHNasrin Hosseini
Nasrin Hosseini
MMMonireh Mohsenzadegan
Monireh Mohsenzadegan
AKAlireza Komaki
Alireza Komaki
MJMohammad Taghi Joghataei
Mohammad Taghi Joghataei
The molecular and chemical properties of neuronal nitric oxide synthase (nNOS) have made it a key mediator in many physiological functions and signaling transduction. The NOS monomer is inactive, but the dimer form is active. There are three forms of NOS, which are neuronal (nNOS), inducible (iNOS), and endothelial (eNOS) nitric oxide synthase. nNOS regulates nitric oxide (NO) synthesis which is the mechanism used mostly by neurons to produce NO. nNOS expression and activation is regulated by some important signaling proteins, such as cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB), calmodulin (CaM), heat shock protein 90 (HSP90)/HSP70. nNOS-derived NO has been implicated in modulating many physiological functions, such as synaptic plasticity, learning, memory, neurogenesis, etc. In this review, we have summarized recent studies that have characterized structural features, subcellular localization, and factors that regulate nNOS function. Finally, we have discussed the role of nNOS in the developing brain under a wide range of physiological conditions, especially long-term potentiation and depression.

28 September 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
MOMojgan Oshaghi
Mojgan Oshaghi
MAMasoumeh Kourosh Arami
Masoumeh Kourosh Arami
MRMaryam Roozbehkia
Maryam Roozbehkia

17 February 2022 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
MAMasoumeh Kourosh Arami
Masoumeh Kourosh Arami
AKAyat Kaeidi
Ayat Kaeidi
SSSaeed Semnanian
Saeed Semnanian

1 May 2023 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
MAMasoumeh Kourosh Arami
Masoumeh Kourosh Arami
AKAlireza Komaki
Alireza Komaki
MZMohammad-Reza Zarrindast
Mohammad-Reza Zarrindast
It is well established that learning and memory are complex processes. They involve and recruit different brain modulatory neurotransmitter systems. Considerable evidence points to the involvement of dopamine (DA) in learning and memory. Manifestations of the synaptic spatial localization of the effect of DA have gained a great deal of interest. Despite the molecular cloning of the five DA receptor subtypes, the underlying signaling of the DA receptors in spatial learning and memory is less compelling. Fluctuations in the DA level in the brain are associated with many diseases that comprise deficits in learning and memory, including Parkinson's disease, Huntington’s disease, schizophrenia, and Alzheimer's disease. This review aims to briefly summarize existing information regarding the memory performance modified by DA. The signaling of the DA system, particularly examining the origin of DA-modulated memory, is also discussed. Then, several kinds of memories in which DA plays a critical role, including reward signaling, working memory, and long-term plasticity, as well as memory consolidation, are also described. Finally, memory impairment in some DA-related neurological disorders is also examined.

1 January 2021 in The Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
MAMasoumeh Kourosh Arami
Masoumeh Kourosh Arami
NHNasrin Hosseini
Nasrin Hosseini
AKAlireza Komaki
Alireza Komaki
Neuroplasticity is referred to the ability of the nervous system to change its structure or functions as a result of former stimuli. It is a plausible mechanism underlying a dynamic brain through adaptation processes of neural structure and activity patterns. Nevertheless, it is still unclear how the plastic neural systems achieve and maintain their equilibrium. Additionally, the alterations of balanced brain dynamics under different plasticity rules have not been explored either. Therefore, the present article primarily aims to review recent research studies regarding homosynaptic and heterosynaptic neuroplasticity characterized by the manipulation of excitatory and inhibitory synaptic inputs. Moreover, it attempts to understand different mechanisms related to the main forms of synaptic plasticity at the excitatory and inhibitory synapses during the brain development processes. Hence, this study comprised surveying those articles published since 1988 and available through PubMed, Google Scholar and science direct databases on a keyword-based search paradigm. All in all, the study results presented extensive and corroborative pieces of evidence for the main types of plasticity, including the long-term potentiation (LTP) and long-term depression (LTD) of the excitatory and inhibitory postsynaptic potentials (EPSPs and IPSPs).

11 August 2020 in International Journal of Neuroscience
Verified
Journal Article
Closed access
MAMasoumeh Kourosh Arami
Masoumeh Kourosh Arami
MJMohammad-Taghi Joghataei
Mohammad-Taghi Joghataei
AKAlireza Komaki
Alireza Komaki
MGMasoumeh Gholami
Masoumeh Gholami
ZNZohreh Najafi
Zohreh Najafi
MLMostafa Lavaie
Mostafa Lavaie
In this study, we investigated the effect of long-term administration of orexin receptor 1 (OXR1) antagonist on naloxone-precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine-dependent rats. Wistar rats received subcutaneous (s.c.) injections of morphine (6, 16, 26, 36, 46, 56, and 66 mg/kg, 2 ml/kg) at an interval of 24 hours for 7 days. In chronic groups, the OXR1 antagonist, SB-334867 (20 mg/kg, i.p.), or its vehicle, was injected repetitively from postnatal day 1 (PND1)-PND23 and then for the following seven days before each morphine injection. Meanwhile, in acute groups, SB-334867, or its vehicle, was administered before each morphine injection. In groups of rats that were designated for withdrawal experiments, naloxone (2.5 mg/kg, i.p.) was administered after the last injection of morphine. In the formalin-induced pain, the effect of OXR1 inhibition on the antinociceptive effects of morphine was measured by injecting formalin after the final morphine injection. Animals that received long-term SB-334867 administration before morphine injection demonstrated a significant reduction in chewing, defecation, diarrhea, grooming, teeth chattering, wet-dog shake, and writhing. Inhibiting OXR1 for a long time increased formalin-induced nociceptive behaviors in interphase and phase II of the formalin-induced pain. Our results indicated that the inhibition of OXR1 significantly reduces the development of morphine dependence and behavioral signs elicited by the administration of naloxone in morphine-dependent rats. Furthermore, the prolonged blockade of OXR1 might be involved in formalin-induced nociceptive behaviors.